| pubmed-article:3244560 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0006644 | lld:lifeskim |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0015259 | lld:lifeskim |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0035253 | lld:lifeskim |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0002349 | lld:lifeskim |
| pubmed-article:3244560 | lifeskim:mentions | umls-concept:C0070345 | lld:lifeskim |
| pubmed-article:3244560 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:3244560 | pubmed:dateCreated | 1989-5-26 | lld:pubmed |
| pubmed-article:3244560 | pubmed:abstractText | The purpose of this study was to examine the resting and exercise response patterns of plasma Peptide F immunoreactivity (ir) to altitude exposure (4300 m) and caffeine ingestion (4 mg.kg b.w.-1). Nine healthy male subjects performed exercise tests to exhaustion (80-85% VO2max) at sea level (50 m), during an acute altitude exposure (1 hr, hypobaric chamber, 4300 m) and after a chronic (17-day sojourn, 4300 m) altitude exposure. Using a randomized, double-blind/placebo experimental design, a placebo or caffeine drink was ingested 1 hour prior to exercise. Exercise (without caffeine) significantly (p less than 0.05) increased plasma Peptide F ir values during exercise at chronic altitude only. Caffeine ingestion significantly increased plasma Peptide F ir concentrations during exercise and in the postexercise period at sea level. Conversely caffeine ingestion at altitude resulted in significant reductions in the postexercise plasma Peptide F ir values. The results of this study demonstrate that the exercise and recovery response patterns of plasma Peptide F ir may be significantly altered by altitude exposure and caffeine ingestion. These data support further study examining relationships between Peptide F (and other enkephalin-containing polypeptides) and epinephrine release in response to these types of physiological stresses. | lld:pubmed |
| pubmed-article:3244560 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3244560 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3244560 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3244560 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3244560 | pubmed:issn | 0196-9781 | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:CymermanAA | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:GordonS ESE | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:KraemerW JWJ | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:RockP BPB | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:MarchitelliL... | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:FulcoC SCS | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:RossH HHH | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:BonnerJ PJP | lld:pubmed |
| pubmed-article:3244560 | pubmed:author | pubmed-author:CruthirdsC... | lld:pubmed |
| pubmed-article:3244560 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3244560 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:3244560 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3244560 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3244560 | pubmed:pagination | 1115-9 | lld:pubmed |
| pubmed-article:3244560 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:meshHeading | pubmed-meshheading:3244560-... | lld:pubmed |
| pubmed-article:3244560 | pubmed:articleTitle | Influence of altitude and caffeine during rest and exercise on plasma levels of proenkephalin peptide F. | lld:pubmed |
| pubmed-article:3244560 | pubmed:affiliation | Exercise Physiology Division, U.S. Army Research Institute of Environmental Medicine, Natick, MA 01760-5007. | lld:pubmed |
| pubmed-article:3244560 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3244560 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:3244560 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
